Background: Bronchodilator {P 2 selective adrenergic drug-salbutamol) causes bronchodilation and increases the vital capacity, tidal volume and total lung capacity and reduces gas trapping. Use of bronchodilator in patients undergoing Off-pump coronary artery bypass graft (OPCABG) may lead to better preservation of pulmonary function.
Introduction
Coronary artery bypass grafting is one of the procedures with the highest impact in the history of medicine". Among the post cardiac surgical complications, respiratory complication is one of the leading causes of postoperative morbidity and can prolong hospital stay and increases costs. 2 Pulmonary impairment after cardiac surgery is believed to be multifactorial and reflects the combined effects of general anesthesia, surgical factor (median sternotomy, plurotomy and harvesting of internal mammary artery (IMA) and cardiopulmonary bypass (CPS). Coronary artery bypass grafting performed without CPS results in less inflammatory response and hence pulmonary function is better preserved postoperatively 3 . To reduce postoperative pulmonary complications respiratory physiotherapy and bronchodilators are used preoperativelywhich improve patients pulmonary status. Bronchodilator (() 2 selective adrenergic drug-salbutamol) act on () 2 receptor on bronchial smooth muscle. By dilatation of bronchial smooth muscle it increases the vital capacity, tidal volume, total lung capacity and reduces gas trapping 4 . Bronchodilator also inhibit histamine release by stabilizing of mast cell membrane, inhibit microvascular leakage and increase mucocillarytransport by increasing cilliary activity or by affecting the composition of mucous secretion. 5 In this study, we have tried to evaluate the role of bronchodilator in relation to pulmonary function and respiratory outcome after Off-pump coronary artery bypass graft (OPCABG).
Methods
This prospective cohort study was carried out in the department of cardiac surgery, BSMMU, Dhaka, Bangladesh, from July 2009 to Jun 2011. This study included 50 patients of multi-vessels coronary artery disease with impaired pulmonary function who underwent Off-pump CABG, randomized into two groups, 25 patients in each group. Group-I patients were treated by bronchodilator (syrup Salbutamol) 0.05mg/kg body weight for 2 weeks preoperatively. Group-II patients underwent off-pump CABG without bronchodilator preoperatively having mild to moderate impaired pulmonary function. Ethical approval was taken from institutional review board of BSMMU and informed written consent was taken from each individual patient after briefing the merits and demerits of using brorichodilator preoperatively. Those with severe impaired pulmonary function and those who did not give consent for study were excluded .Statistical analysis were performed using independent student's 't' test and chi square test. P value <0.05 was considered as statistically significant.
Results
Mean±SE value of mechanical ventilation time after operation in group -I was 14.25±0.85 hours and in group -II was 16.88±0.85 hours.Mean ±SE value of ICU stay after surgery was 98.64±2.07 hours in group I and 110.56±2.36 hours in group II. Both results were statistically significant (P=0.042 and P=0.001 respectively). Spirometry was done in both groups of patients after admission, day before operation and on the 7th postoperative day. TheFVC and FEV 1 after admission were not statistically significant (P>0.05). On the day before surgery the values of FVC and FEV 1 were increased (more in group 1 who were treated with bronchodilator) and on the 7th postoperative day the value were decreased (more in group-II who were not treated with bronchodilator). The results were found statistically significant in between two groups (P<0.05). FVC to FEV 1 ratio was not statistically significant all over the study period in between groups. Arterial blood gas analysis was done pre and postoperatively in both groups of patients. Significant difference were found in PaO2 and PaCO2 at half an hour after extubation and on 1st POD (P<0.05). Mean ±SE value of postoperative hospital day in group 1 was 8.88±0.24 days and in group-II was 10.14±0.43 days. It was found statistically significant difference in respect to hospital stay in days between two groups (p=0.014 ). Post-operative pulmonary complications were found in both groups of patients. In group-1, one (4%) patient was found with pleural effusion and one (4%) patient with atelectasis. but in group-II, one (4%) patient was found with pleural effusion and five (20%) patients were found with atelectasis. 
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Discussion
This study included 50 patients of multi-vessels coronary artery disease with impaired pulmonary function who underwent off-pump CABG. They were randomized into two groups, 25 patients in each group; group-I patients underwent off-pump CABG who were given bronchodilator (salbutamol) preoperatively having mild to moderate impaired pulmonary function and group-II patients underwent off-pump CABG who were not given bronchodilator preoperatively having mild to moderate impaired pulmonary function.
Mean±SE value age in group-I was 51.88±1.70 years and in group-II was 54.60± 1.65 years. The age difference between the two groups were not statistically significant (P=0.258) and the mean age of people with coronary artery disease in this study is 53.24 years which is consistent with the study done by Lizak et al and Manganas et al 6 · 7 . In this study male were dominant in both groups. In group-I, 80 % and group-II, 84% were male. This finding suggest that atherosclerotic coronary artery disease is more prevalent in male as is supported by Lizak et al 6 . Extent of coronary artery disease between the groups demonstrates that triple vessels disease (TVD), double vessels disease (DVD), and left main {LM) were Post-operative hospital stay in days in both groups of patients was observed. The Mean± SE value was 8.88±0.24 days in group-I and 10.14±0.43 days in group-II. Statistically significant difference were seen in respect to hospital stay in between two groups (P<0.014). We could not compare the results due to scarcity of literature. Early post-operative pulmonary complications were found in both groups of patients. In group-I, one patient was found with pleural effusion and one patient with atelectasis. But in group-II, one patient with pleural effusion and five patients with atelectasis were found (table IX) . The result is consistent with the study done by Lizak and colleagues 6 .
Conclusion
Our results suggest that use of bronchodilator preoperatively in patient's undergoing off-pump CABG with impaired pulmonary function leads to reduced mechanical ventilation time, less ICU stay after surgery as well as better preservation of post-operative pulmonary function, reduction of post-operative pulmonary complications and reduced total postoperative hospital stay after surgery.
